Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CGNX vs ITRI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CGNX Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 5–5 Matrix Metrics)

CGNX Overall Winner 6-Pillar Tally: CGNX 5 – 1 ITRI Matrix Metrics: CGNX 5 – 5 ITRI

As of Nov 16, 2026, Cognex Corp (CGNX) is the stronger overall head-to-head candidate over Itron Inc (ITRI) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CGNX carries a Unified Composite Score of 59.5/100 (HOLD) at $48.06 (24.7x Forward P/E, 25.0% operating margin), whereas ITRI carries 46.0/100 (HOLD) at $96.02 (13.8x Forward P/E, 13.7% operating margin).

  • Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile ITRI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 54.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CGNX vs ITRI
CGNX NASDAQ Head-to-Head Winner
Cognex Corp
Industrial Instruments For Measurement, Display, And Control
$48.06
-3.9% 1D
Market Cap $8.5B
TTM Revenue $1.13B
Forward P/E 24.7x
Beta / 30D Vol 2.19β · 65% Vol
Unified Composite Score
59.5 / 100 HOLD
Tech 45.0 Fund 54.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.1%), weak momentum, RSI 36
RSI-14: 35.9 · SMA20: $53.86 · SMA50: $57.80
ITRI NASDAQ
Itron Inc
Instruments For Meas & Testing Of Electricity & Elec Signals
$96.02
-0.04% 1D
Market Cap $4.2B
TTM Revenue $2.32B
Forward P/E 13.8x
Beta / 30D Vol 1.04β · 40% Vol
Unified Composite Score
46.0 / 100 HOLD
Tech 33.0 Fund 43.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 54
RSI-14: 54.3 · SMA20: $94.74 · SMA50: $91.26

6-Pillar Scorecard Institutional Category Breakdown (CGNX 5 – 1 ITRI)

Columns: Metric · CGNX · ITRI
1. Valuation Multiples ITRI
Forward P/E 24.7x 13.8x
Trailing P/E 35.5x 16.0x
PEG Ratio 2.71x 0.75x
EV / Revenue 7.0x 1.8x
2. Growth & Scale CGNX
Revenue Growth (YoY) +13.2% +3.0%
Earnings Growth (YoY) +400.0% +14.2%
TTM Revenue (USD) $1.13B $2.32B
Market Cap $8.5B $4.2B
3. Profitability & Quality CGNX
Gross Margin 69.7% 40.7%
Operating Margin 25.0% 13.7%
Net Profit Margin 21.5% 12.0%
Return on Equity (ROE) 15.1% 16.4%
4. Balance Sheet & Cash Flow CGNX
Cash Generation (TTM) $286M $379M EBITDA
Cash Flow Margin 25.4% 16.3% EBITDA Mgn
Net Cash / Leverage $624M Net Cash $38.74 Book/Sh · 16.4% ROE
Dividend Yield 0.66% None (0.00%)
5. Options & Positioning CGNX
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 53.5% (16th %ile) 28.6% (<1st %ile)
Put/Call OI Skew 1.96x (Put-Skewed) N/A
OBV Trend / Tech Phase ACCUMULATION · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CGNX
OpEx & R&D Intensity 44.7% of Rev ($503M) 27.0% of Rev ($627M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Scientific & Technical Instruments Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CGNX (5) vs ITRI (5)
Institutional Metric CGNX ITRI Criterion Row Edge
Market Capitalization
Scale
$8.5B $4.2B Larger Scale CGNX
Trailing P/E Ratio
Valuation
35.5x 16.0x Lower Multiple ITRI
Forward P/E Ratio
Valuation
24.7x 13.8x Lower Multiple ITRI
Revenue Growth (YoY)
Growth
+13.2% +3.0% Higher Growth CGNX
Operating Margin (TTM)
Profitability
25.0% 13.7% Higher Margin CGNX
Net Profit Margin
Profitability
21.5% 12.0% Higher Margin CGNX
Return on Equity (ROE)
Capital Efficiency
15.1% 16.4% Higher ROE ITRI
52-Week Range Position
Momentum
35% ($35–$73) 60% ($78–$108) Stronger Trend ITRI
Beta / 30D Volatility
Risk Regime
2.19β · 65% Vol 1.04β · 40% Vol Lower Realized Risk ITRI
Unified Institutional Score
Composite Signal
59.5 / 100 (HOLD) 46.0 / 100 (HOLD) Higher Composite CGNX
Trailing 12M Revenue (USD)
Operating Scale
$1.13B $2.32B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
69.7% 40.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.71x PEG · 7.0x EV/Rev 0.75x PEG · 1.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$286M ($624M Net Cash) $379M EBITDA ($38.74 Book/Sh · 16.4% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ITRI +26.61 pp
CGNX: -10.98% · ITRI: +15.63%
3M Horizon ITRI +24.04 pp
CGNX: -24.21% · ITRI: -0.17%
6M Horizon ITRI +41.21 pp
CGNX: -22.37% · ITRI: +18.84%
1Y Horizon CGNX +33.19 pp
CGNX: +29.72% · ITRI: -3.47%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CGNX vs ITRI. Trailing 12-month operating profitability (CGNX 25.0% vs ITRI 13.7%) and valuation multiples (CGNX 24.7x vs ITRI 13.8x Forward P/E) are benchmarked directly in Pillar 4 below.

CGNX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.13B
Gross Margin69.7%
Op. Margin25.0%
ROE / Fwd P/E15.1% · 24.7x
ITRI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.32B
Gross Margin40.7%
Op. Margin13.7%
ROE / Fwd P/E16.4% · 13.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CGNX BREAKDOWN
121d in phase · OBV ACCUMULATION
Current IV 53.5%
IV Percentile 16th %ile
Put/Call OI Skew 1.96x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact CGNX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ITRI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 28.6%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ITRI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CGNX Moat Profile Scale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $8.5B market capitalization and 25.0% operating margin.
OpEx & R&D Reinvestment 44.7% of Rev ($503M)
90D Engineering Disclosures 0 Published
ITRI Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $4.2B market capitalization and 13.7% operating margin.
OpEx & R&D Reinvestment 27.0% of Rev ($627M)
90D Engineering Disclosures 0 Published

Investor FAQ CGNX vs ITRI Key Questions & Quantitative Answers

As of Nov 16, 2026, Cognex Corp (CGNX) is the stronger overall head-to-head candidate over Itron Inc (ITRI) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CGNX carries a Unified Composite Score of 59.5/100 (HOLD) at $48.06 (24.7x Forward P/E, 25.0% operating margin), whereas ITRI carries 46.0/100 (HOLD) at $96.02 (13.8x Forward P/E, 13.7% operating margin). Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile ITRI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 54.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CGNX leads the Growth & Scale pillar: CGNX posts +13.2% YoY revenue growth and +400.0% YoY earnings growth on $1.13B TTM revenue (69.7% gross margin, 25.0% operating margin), compared with ITRI at +3.0% YoY revenue growth and +14.2% YoY earnings growth on $2.32B TTM revenue (40.7% gross margin, 13.7% operating margin). On trailing 12-month operating scale, CGNX generates $1.13B in USD-normalized revenue versus $2.32B for ITRI. In operating R&D and SG&A reinvestment, CGNX deploys 44.7% of Rev ($503M) (0 90-day corporate R&D disclosures) versus 27.0% of Rev ($627M) (0 disclosures) for ITRI.

ITRI screens cheaper on headline valuation multiples. CGNX trades at 24.7x Forward P/E, 35.5x Trailing P/E, 2.71x PEG, and 7.0x EV/Revenue (25.4% FCF margin), whereas ITRI trades at 13.8x Forward P/E, 16.0x Trailing P/E, 0.75x PEG, and 1.8x EV/Revenue (16.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGNX (15.1% ROE) versus ITRI (16.4% ROE) capital efficiency.

In options market volatility and institutional positioning, CGNX carries 53.5% implied volatility (16th %ile, Compressed (<25th %ile)), a 1.96x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.19β · 65% Vol realized risk). By comparison, ITRI carries 28.6% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.04β · 40% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.